Table 6.
Different answers to the knowledge of COPD between intervention group and control group
| |
Intervention |
Control |
P value |
|---|---|---|---|
| Group(n = 49) | Group(n = 61) | ||
| Prevalence of COPD in China |
|
|
NS |
| Average of reported prevalence |
11.2% |
13.6% |
|
| Average of reported prevalence |
0.2–50.0% |
0.2–70.0% |
|
| Most important risk factors of COPD (% of respondents) |
NS |
||
| Smoking |
91.8% |
95.1% |
|
| Infection |
8.2% |
4.9% |
|
| Most valuable indication for early diagnosis of COPD (% of respondents) |
NS |
||
| Symptoms |
16.3% |
18.0% |
|
| Physical examination |
2.0% |
8.2% |
|
| Spirometry |
89.8% |
86.9% |
|
| Chest x-ray |
4.1% |
8.2% |
|
| First choice exam for confirming diagnosis (% of respondents) |
NS |
||
| Spirometry |
55.1% |
54.1% |
|
| Medical history (chronic bronchitis or emphysema) |
22.4% |
23.0% |
|
| Symptoms |
20.4% |
24.6% |
|
| First-line prescribed medicine for COPD |
0.009 |
||
| Beta2-agonists |
49.0% |
23.0% |
|
| Combined beta2-agonists with corticosteroid |
30.6% |
42.7% |
|
| Inhaled corticosteroid |
8.2%% |
11.8% |
|
| Anticholinergic |
4.1% |
11.0% |
|
| Theophylline |
6.1% |
8.2% |
|
| First-line prescribed medicine for COPD exacerbation (% of respondents) |
0.004 |
||
| Antibiotics |
42.9% |
31.1% |
|
| Oral corticosteroid |
14.3% |
21.3% |
|
| Combined beta2-agonists with corticosteroid |
14.3% |
19.7% |
|
| Beta2-agonists bronchodilators |
24.5% |
11.5% |
|
| Anticholinergic agents |
2.0% |
3.3% |
|
| Theophylline |
0.0% |
4.9% |
|
| Provide smoking cessation counseling |
NS |
||
| Always |
97.0% |
98.0% |
|
| Occasionally |
3.0% |
2.0% |
|
| Suggestions for taking influenza vaccine |
0.03 |
||
| Always |
63.3% |
47.5% |
|
| Occasionally |
36.7% |
52.5% |
|
| Indications for inhaled corticosteroid |
NS |
||
| Know well |
40.8% |
27.9% |
|
| Know moderately |
26.6% |
39.3% |
|
| Know poor | 32.6% | 32.8% | |